Taiwan FDA registration 5d3cb2c4f9e30bb42b048c597429505c
"Abbot" drops acquired immunodeficiency virus test quality control group
TW: “亞培” 滴就靈後天免疫不全病毒檢驗品管組
Taiwan·Risk Class 2·ABBOTT DIAGNOSTICS MEDICAL CO., LTD.-CHIBA PLANT·Registered May 10, 2021 – May 10, 2026ExpiredRegistration details
- Analysis ID
- 5d3cb2c4f9e30bb42b048c597429505c
- Customs Code
- DHA05603464702
Company information
- Manufacturer
- ABBOTT DIAGNOSTICS MEDICAL CO., LTD.-CHIBA PLANT
- Manufacturer Country
- Japan
- Authorized Representative
- Abbott Rapid Diagnostics Health Corp.
Product details
- Intended Use
- This product is a quality control reagent used in conjunction with Determine HIV Ultra or Determine HIV Early Detect.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- May 10, 2021
- Expiry Date
- May 10, 2026
About this record
Access comprehensive regulatory information for "Abbot" drops acquired immunodeficiency virus test quality control group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5d3cb2c4f9e30bb42b048c597429505c and manufactured by ABBOTT DIAGNOSTICS MEDICAL CO., LTD.-CHIBA PLANT. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices